Source: International Congress 2019 – Insights into physiological diagnostic services
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Raposo (Lisboa, Portugal), R. Monteiro (Lisboa, Portugal), I. Arranhado (Lisboa, Portugal), J. Picado (Lisboa, Portugal), A. Oliveira (Lisboa, Portugal), J. Valença (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal). The effect of salbutamol on pulmonary diffusing capacity. 3915

Member's Comments

No comment yet.

Related content which might interest you: The effect of tiotropium on the pulmonary diffusing capacity Source: Eur Respir J 2007; 30: Suppl. 51, 772s Year: 2007 The effects of lung volume reduction treatment on diffusing capacity and gas exchange Source: Eur Respir Rev, 29 (158) 190171; 10.1183/16000617.0171-2019 Year: 2020 Insulin therapy preserves pulmonary diffusing capacity Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005 Diffusing capacity and oxygen saturation response to bronchodilation in patients with severe COPD Source: Eur Respir J 2007; 30: Suppl. 51, 600s Year: 2007 CO diffusing capacity: are adjustments of CO diffusing capacity necessary? Source: Annual Congress 2006 - Implementation of the new standards on clinical pulmonary function testing Year: 2006 ACE-inhibition improves peak exercise oxygen uptake and ventilation in COPD: an effect unrelated to pulmonary function Source: Eur Respir J 2003; 22: Suppl. 45, 205s Year: 2003 Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD Source: ERJ Open Res, 7 (1) 00706-2020; 10.1183/23120541.00706-2020 Year: 2021 The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021 Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Source: Eur Respir J 2003; 21: 86-94 Year: 2003 Methacholine-induced bronchoconstriction is associated with a decrease in NO airway wall diffusing capacity and an increase in alveolar NO concentration Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008 Effect of He-O2 breathing and inhaled salbutamol on expiratory flow limitation and dynamic hyperinflation in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002 Diffusing capacity of the lung for carbon monoxide (DLCO) and pulmonary blood flow during incremental and intermittent-work exercise tests Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016 Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Effect of heliox on exercise capacity in COPD Source: ERS Course 2017 Year: 2017 Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD Source: Eur Respir J 2008; 32: 1275-1282 Year: 2008 Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 963-965 Year: 2014 Elevation of diffusing lung capacity (TLCO) in asthmatic children as a result of ventilation/perfusion disorder Source: Eur Respir J 2003; 22: Suppl. 45, 495s Year: 2003 Lung diffusion measurement: effects of alveolar volume changes on diffusing capacity and implications in restrictive lung disease Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases Year: 2004 The effect of tiotropium on lung dynamic hyperinflation and treadmill exercise capacity in mild to moderate COPD Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012